CAN SEVERE VINCRISTINE NEUROTOXICITY BE PREVENTED

被引：88

作者：

DESAI, ZR ^{[1
]}

VANDENBERG, HW ^{[1
]}

BRIDGES, JM ^{[1
]}

SHANKS, RG ^{[1
]}

机构：

[1] QUEENS UNIV BELFAST,DEPT THERAPEUT & PHARMACOL,BELFAST BT12 6BA,NORTH IRELAND

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1982年 / 8卷 / 02期

关键词：

D O I：

10.1007/BF00255486

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：211 / 214

页数：4

共 9 条

[1] NEUROMYOPATHY OF VINCRISTINE IN MAN - CLINICAL, ELECTROPHYSIOLOGICAL AND PATHOLOGICAL STUDIES [J].

BRADLEY, WG ;

LASSMAN, LP ;

PEARCE, GW ;

WALTON, JN .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 1970, 10 (02) :107-+

[2] VINCRISTINE NEUROPATHY - CLINICAL AND ELECTROPHYSIOLOGICAL OBSERVATIONS [J].

CASEY, EB ;

JELLIFE, AM ;

LEQUESNE, PM ;

MILLETT, YL .

BRAIN, 1973, 96 :69-86

[3]

DORR RT, 1980, CANCER CHEMOTHERAPY, P687

[4]

JACKSON DV, 1978, CLIN PHARMACOL THER, V24, P101

[5] VINCRISTINE-INDUCED NEUROPATHY - A CLINICAL STUDY OF 50 LEUKEMIC PATIENTS [J].

SANDLER, SG ;

TOBIN, W ;

HENDERSON, ES .

NEUROLOGY, 1969, 19 (04) :367-+

[6]

SHAW RICHARD K, 1964, CANCER CHEMOTHERAP REP, V42, P45

[7] RADIOIMMUNOASSAY OF VINBLASTINE AND VINCRISTINE [J].

TEALE, JD ;

CLOUGH, JM ;

MARKS, V .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (02) :169-172

[8] HIGH INCIDENCE OF VINCRISTINE-INDUCED NEUROPATHY IN LYMPHOMAS [J].

WATKINS, SM ;

GRIFFIN, JP .

BRITISH MEDICAL JOURNAL, 1978, 1 (6113) :610-612

[9] NEUROTOXICITY OF COMMONLY USED ANTINEOPLASTIC AGENTS .2. [J].

WEISS, HD ;

WALKER, MD ;

WIERNIK, PH .

NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (03) :127-133

← 1 →